Senti Biosciences (SNTI) Depreciation & Amortization (CF) (2021 - 2025)

Senti Biosciences has reported Depreciation & Amortization (CF) over the past 5 years, most recently at $893000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 4.7% year-over-year to $893000.0; the TTM value through Dec 2025 reached $3.6 million, down 4.82%, while the annual FY2025 figure was $3.6 million, 5.24% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $893000.0 at Senti Biosciences, down from $904000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.3 million in Q3 2023 and troughed at $200000.0 in Q2 2021.
  • A 5-year average of $685578.9 and a median of $893000.0 in 2025 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 225.0% in 2023 and later plummeted 30.77% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $257000.0 in 2021, then surged by 75.88% to $452000.0 in 2022, then soared by 119.47% to $992000.0 in 2023, then dropped by 5.54% to $937000.0 in 2024, then fell by 4.7% to $893000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SNTI at $893000.0 in Q4 2025, $904000.0 in Q3 2025, and $914000.0 in Q2 2025.